Trial Profile
Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Regadenoson (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- 17 Jul 2018 Status changed from recruiting to completed.
- 30 Apr 2018 Planned primary completion date changed from 1 Mar 2018 to 14 Jun 2018.
- 07 Apr 2017 New trial record